During the past decade, Centro de Pesquisas Oncologicas - CEPON conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 18 clinical trials were completed, i.e. on average, 72% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Pesquisas Oncologicas - CEPON" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Latin American Cooperative Oncology Group" with 4 trials sponsored, "Clovis Oncology, Inc." with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Pesquisas Oncologicas - CEPON" #1 collaborator was "Avon Institute" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "EVA - Grupo Brasileiro de Tumores Ginecológicos" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Pesquisas Oncologicas - CEPON" are "Breast Cancer" (4 trials), "Epithelial Ovarian Cancer" (2 trials), "Fallopian Tube Cancer" (2 trials), "Leukemia, Myelomonocytic, Chronic" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Centro de Pesquisas Oncologicas - CEPON" in a lesser frequency.

Most popular intervention types in "Centro de Pesquisas Oncologicas - CEPON" are "Drug" (32 trials), "Other" (3 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Cyclophosphamide" (5 trials), "Atezolizumab" (4 trials), "Doxorubicin" (4 trials) and "Azacitidine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Pesquisas Oncologicas - CEPON" are 30 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro de Pesquisas Oncologicas - CEPON". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Centro de Pesquisas Oncologicas - CEPON, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Pesquisas Oncologicas - CEPON, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".